What is the ticker symbol for Caladrius Biosciences?

Caladrius Biosciences trades under the ticker CLBS on NASDAQ.

What sector does Caladrius Biosciences operate in?

Caladrius Biosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CLBS in a portfolio?

PortView shows CLBS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Caladrius Biosciences (CLBS) Stock Analysis

NASDAQHealthcareBiotechnology

$0.43-16.75%

1-year price historyRange $0.41 – $1.24

What Caladrius Biosciences does

Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical company primarily engaged in the development and commercialization of cellular therapies. These therapies aim to either reverse various diseases or stimulate the regeneration of compromised tissue. The company's pipeline includes several key investigational therapies: HONEDRA, which has received the prestigious SAKIGAKE designation, is undergoing Phase II clinical trials as a potential treatment for critical limb ischemia; XOWNA is currently in Phase IIb trials targeting coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy, is being evaluated for chronic kidney disease in patients prior to requiring dialysis. Previously known as NeoStem, Inc., the firm adopted its current name, Caladrius Biosciences, Inc., in June 2015. Established in 1980, the company maintains its corporate headquarters in Basking Ridge, New Jersey.

Key metrics

Market cap

$3.35M

P/E (TTM)

-1.08

EPS (TTM)

$-0.39

Beta

0.91

Dividend yield

0.00%

Revenue / share

$0.01

CEO

David Mazzo

ETFs linked to CLBS

Broad-market and Healthcare sector ETFs an investor holding Caladrius Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CLBS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CLBS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Caladrius Biosciences?: Caladrius Biosciences trades under the ticker CLBS on NASDAQ.
Which exchange is CLBS listed on?: CLBS is listed on NASDAQ.
What sector does Caladrius Biosciences operate in?: Caladrius Biosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CLBS in a portfolio?: PortView shows CLBS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.